Skip to main content

Training Network for Optimizing Adoptive T cell Therapy of Cancer

Project description

Optimisation of T cell therapy

Adoptive T cell therapy, which employs the patient's own cells as a weapon, is considered a breakthrough in the treatment of cancer. However, the production of such immunotherapy products lacks harmonisation with clinical studies. The EU-funded T-OP project aims to bridge this gap by bringing together interdisciplinary teams of scientists working in cell therapy, immunology, protein engineering and bioinformatics alongside large and medium-sized enterprises. The scientific work will focus on cytokines and their role in the therapeutic outcome of adoptive cell therapy, aiming to determine the optimal combination. The project's results will lead to the development of safer and improved immunotherapeutics.

Field of science

  • /natural sciences/biological sciences/biochemistry/biomolecules/proteins
  • /medical and health sciences/basic medicine/immunology
  • /medical and health sciences/clinical medicine/cancer
  • /medical and health sciences/medical biotechnology/cells technologies

Call for proposal

H2020-MSCA-ITN-2020
See other projects for this call

Funding Scheme

MSCA-ITN-ETN - European Training Networks

Coordinator

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Address
Geschwister Scholl Platz 1
80539 Muenchen
Germany
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 758 365,20

Participants (11)

DANMARKS TEKNISKE UNIVERSITET
Denmark
EU contribution
€ 297 522
Address
Anker Engelundsvej 1 Bygning 101 A
2800 Kgs Lyngby
Activity type
Higher or Secondary Education Establishments
STICHTING VUMC
Netherlands
EU contribution
€ 265 619,88
Address
De Boelelaan 1117
1081 HV Amsterdam
Activity type
Research Organisations
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
EU contribution
€ 274 802,04
Address
Rue De Tolbiac 101
75654 Paris
Activity type
Research Organisations
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL
Germany
EU contribution
€ 252 788,40
Address
Paul-ehrlich-strasse 51-59
63225 Langen
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
REGION HOVEDSTADEN
Denmark
EU contribution
€ 595 044
Address
Kongens Vaenge 2
3400 Hillerod
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
UNIVERSITAT BASEL
Switzerland
EU contribution
€ 281 276,64
Address
Petersplatz 1
4051 Basel
Activity type
Higher or Secondary Education Establishments
ROCHE GLYCART AG
Switzerland
EU contribution
€ 281 276,64
Address
Wagistrasse 10
8952 Schlieren
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
IMMETACYTE LIMITED
United Kingdom
EU contribution
€ 303 172,56
Address
Hawthorn Lane 34 Heald Court 3
SK9 5DG Wilmslow
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITE PARIS-SACLAY
France
EU contribution
€ 274 802,04
Address
Immeuble Technologique Entree B Rte De L Orme Aux Merisiers
91190 Saint Aubin
Activity type
Higher or Secondary Education Establishments
MILTENYI BIOTEC BV & CO KG
Germany
EU contribution
€ 252 788,40
Address
Friedrich Ebert Strasse 68
51429 Bergisch Gladbach
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
RESEARCH FUND OF THE HADASSAH MEDICAL ORGANIZATION (R.A)
Israel
EU contribution
€ 263 500,92
Address
Kiryat Hadassah Ein Karem
91120 Jerusalem
Activity type
Research Organisations